Skip to main content
Premium Trial:

Request an Annual Quote

Michael French, Victor Ambros, David Baulcombe, Gary Ruvkun

Premium
MDRNA CEO Michael French has been appointed to the company’s board, and has also been named as president.
 
French joined MDRNA, which previously was known as Nastech Pharmaceutical (see RNAi News, 6/12/2008), in June. He previously served as senior vice president of corporate development at Sirna Therapeutics.
 

 
Victor Ambros, David Baulcombe, and Gary Ruvkun were awarded this year’s Albert Lasker Medical Research Awards for their pioneering efforts in discovering microRNAs.
 
Ambros recently became a professor at the University of Massachusetts Medical School. Baulcombe is a professor at the University of Cambridge, and Ruvkunis a professor at Harvard Medical School.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.